Solid Biosciences Inc. (SLDB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Solid Biosciences Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -2.83x | -1.31x | -1.27x | -0.53x | -2.59x | -4.46x |
| P/B Ratio | 2.74x | 1.19x | 0.97x | 0.22x | 0.90x | 2.98x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 5.66x | 13.72x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | -1315.2% | -530.5% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | -1062.3% | -530.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | -1196.8% | -508.7% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.14x | 5.20x | 8.94x | 9.76x | 9.43x | 6.49x |
| Quick Ratio | 6.14x | 5.20x | 8.94x | 9.76x | 9.43x | 6.49x |
| Leverage | ||||||
| Debt/Equity | 0.12x | 0.18x | 0.21x | 0.13x | 0.01x | 0.04x |
YoY = year-over-year change. Source: FMP..